These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2313275)

  • 21. Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects.
    Treanor JJ; Betts RF
    Vaccine; 1998 Nov; 16(18):1756-60. PubMed ID: 9778752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children.
    Piedra PA; Glezen WP; Mbawuike I; Gruber WC; Baxter BD; Boland FJ; Byrd RW; Fan LL; Lewis JK; Rhodes LJ
    Vaccine; 1993; 11(7):718-24. PubMed ID: 8342319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum.
    Wagner DK; Clements ML; Reimer CB; Snyder M; Nelson DL; Murphy BR
    J Clin Microbiol; 1987 Mar; 25(3):559-62. PubMed ID: 3571460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunological effectiveness of a method for simultaneous immunization against influenza using live and inactivated vaccines].
    Orlov VA; Zhilova GP; Ignat'eva GS; Malikova EV; Efremov BV
    Vopr Virusol; 1982; 27(3):271-5. PubMed ID: 7123907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the enzyme-linked immunosorbent assay to detect serum antibody responses of volunteers who received attenuated influenza A virus vaccines.
    Murphy BR; Tierney EL; Barbour BA; Yolken RH; Alling DW; Holley HP; Mayner RE; Chanock RM
    Infect Immun; 1980 Aug; 29(2):342-7. PubMed ID: 7011972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection.
    Clements ML; Betts RF; Murphy BR
    Lancet; 1984 Mar; 1(8379):705-8. PubMed ID: 6143042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza vaccines.
    Brede HD
    Int Arch Allergy Immunol; 1995 Dec; 108(4):318-20. PubMed ID: 7580301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of IL-2 and IFN-gamma in BALB/c mice immunised with subunit influenza A vaccine in combination with whole cell or acellular DTP vaccine.
    Tamizifar H; Jennings R; Ali SA; Potter CW
    J Med Microbiol; 1997 Jan; 46(1):61-6. PubMed ID: 9003747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines.
    Gorse GJ; Belshe RB; Munn NJ
    J Clin Microbiol; 1988 May; 26(5):911-8. PubMed ID: 3384914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine.
    Muszkat M; Greenbaum E; Ben-Yehuda A; Oster M; Yeu'l E; Heimann S; Levy R; Friedman G; Zakay-Rones Z
    Vaccine; 2003 Mar; 21(11-12):1180-6. PubMed ID: 12559796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin G subclass antibody responses of mice to influenza virus antigens given in different forms.
    Balkovic ES; Florack JA; Six HR
    Antiviral Res; 1987 Oct; 8(3):151-60. PubMed ID: 3426185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
    Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM
    J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
    Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB
    J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
    Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristic of humoral response of elderly to inactivated influenza vaccine.
    Siennicka J
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):389-94. PubMed ID: 9017157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivated influenza virus vaccines in children.
    Ruben FL
    Clin Infect Dis; 2004 Mar; 38(5):678-88. PubMed ID: 14986252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antibody functional activity in immunization with influenza vaccines].
    Naĭkhin AN; Artem'eva SA; Ermachenko TA; Vybornykh EN; Kustikova IuG; Doroshenko EV; Katorgina LG; Denisov GM; Kim TN
    Vopr Virusol; 1993; 38(5):204-7. PubMed ID: 8284916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine.
    Cole KS; Martin JM; Horne WT; Lin CJ; Nowalk MP; Alcorn JF; Zimmerman RK
    Vaccine; 2017 Dec; 35(49 Pt B):6893-6897. PubMed ID: 29132989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunity to influenza virus infection induced by heterologous, inactivated vaccines.
    Potter CW; Jennings R; Nicholson K
    Med Microbiol Immunol; 1978 Nov; 166(1-4):99-108. PubMed ID: 723794
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.